Royal Society of Chemistry, Nanoscale, 36(8), p. 16192-16196
DOI: 10.1039/c6nr03878f
Full text: Unavailable
A glycosaminoglycan mimetic was attached to the surface of solid and mesoporous silica nanoparticles to create novel antiviral agents against herpes simplex type 1 and type 2 viruses. The nanoparticles act as viral entry inhibitors that appear to block viral attachment and penetration into susceptible cells.